In a multicenter study, cross-modal imaging aligned with biopsy-confirmed histopathology and showed high physician reader agreement, supporting its FDA-cleared role in clinical assessment featuring Enspectra Health
/
DateNov 25 2025
In this diagnostic study, 65 participants undergoing skin biopsy were imaged with a novel cross-modal system. Expert readers used traditional hematoxylin and eosin histopathology to... Read More →


















